Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep by Mévélec, Marie-Noëlle et al.
Original article
Mic1-3 Knockout Toxoplasma gondii is a good candidate
for a vaccine against T. gondii-induced abortion in sheep
Marie-Noe ¨lle ME ´VE ´LEC
1*,C e ´line DUCOURNAU
1, Alaa BASSUNY ISMAEL
1,
Michel OLIVIER
2,E ´douard SE `CHE
3, Maryse LEBRUN
4, Daniel BOUT
1,
Isabelle DIMIER-POISSON
1
1 Universite ´ Franc ¸ois Rabelais, INRA, UMR 0483 Universite ´-INRA d’Immunologie Parasitaire,
Vaccinologie et Biothe ´rapie Anti-infectieuse, IFR136 Agents Transmissibles et Infectiologie, UFR de Pharmacie,
31 avenue Monge, 37200 Tours, France
2 INRA, UR1282, Infectiologie Animale et Sante ´ Publique, 37380 Nouzilly, France
3 VitamFero, UFR de Pharmacie, 31, avenue Monge, 37200 Tours, France
4 Universite ´ de Montpellier 2, CNRS, UMR 5539 Universite ´-CNRS, 34090 Montpellier, France
(Received 18 November 2009; accepted 12 April 2010)
Abstract – This study assessed the effectiveness of a mutant strain of Toxoplasma gondii (RH strain) lacking
the mic1 and mic3 genes (Mic1-3KO) against Toxoplasma abortion in sheep. Ewes were inoculated
subcutaneously with 10
5 Mic1-3KO tachyzoı ¨tes in three independent experiments. Following vaccination,
Mic1-3KO induced a mild febrile response and serum IgG antibodies, which persisted throughout the
experiments. Tissue cysts formed in the sheep, but were not, under our experimental conditions, infectious
when given orally. Ewes were mated two months after vaccination and were orally challenged with the PRU
strain of T. gondii at mid-gestation (400 oocysts in Experiments 1 and 2; 100 oocysts in Experiment 3).
Challenge of vaccinated pregnant ewes resulted in a slight febrile response, whereas unvaccinated ewes
developed a more severe, characteristic febrile response of longer duration. After challenge, all unvaccinated
ewesaborted whereas62%,91% and64% (Experiments 1,2 and3 respectively)of thelambsfromvaccinated
ewes were viable, with no clinical signs of infection. Mic1-3KO was as effective as S48, the strain used as a
live vaccine for sheep (Toxovax
 ). A dose of 10
5 Mic1-3KO tachyzoites was sufﬁcient to induce protection
(versus a dose of 2 · 10
6). Both subcutaneous and intraperitoneal injections were effective. Moreover,
preliminaryresultsshowedthepotentialofMic1-3KOtoreducethedevelopmentoftissuecystsinlambsborn
to vaccinated ewes. This study demonstrates that Mic1-3KO is a potent vaccine candidate.
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1. INTRODUCTION
Toxoplasmosis is a cosmopolitan zoonotic
disease caused by the coccidian protozoan
Toxoplasma gondii, an obligatory intracellular
parasite. T. gondii is capable of infecting all
warm-blooded animals including humans [17].
Toxoplasmosis in animals is of great eco-
nomic importance worldwide because it causes
abortions and stillbirths, especially in sheep and
goats [7, 8]. The most recent surveys on sero-
prevalence in sheep were conducted in Brazil
(29.41%), southern Italy (49.9%, 28.5%) and
Lithuania (42.1%) [10, 20, 37, 38]. The differ-
ences observed may be due to the frequency
of felines on farms, climatic variations and
age of animals.
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tective Th1-type cell mediated immunity [23]
and will not normally abort due to toxoplas-
mosis in future pregnancies [5, 29, 35]. This
suggests that a strategy based on vaccination
should be successful. A vaccine would also
reduce or prevent formation of T. gondii tissue
cysts, a source of contamination for humans,
since sheep are animals used for food
[11, 28].
A vaccine based on live S48 Toxoplasma
tachyzoites is available (Ovilis Toxovax
 , Inter-
vet, Angers, France) and protects pregnant
sheep against toxoplasmosis [6]. In ewes, 72
to 80% of lambs resulting from mothers vacci-
nated with Ovilis Toxovax
  are viable versus
18% for lambs from unvaccinated sheep [3].
S48 is a type I strain [18], which is very virulent
in mice [18, 24], but has lost the ability to form
tissue cysts in intermediate hosts and oocysts in
cats [1]. One strategy for developing safer vac-
cines against toxoplasmosis is to create speciﬁc
gene-deﬁcient strains of T. gondii. Genetic dele-
tions in these strains may prevent virulence
reversion in contrast to naturally attenuated
strains.
The RH strain of T. gondii (type I) is very
virulent in mice but has lost the ability to form
oocysts in cats [12]. Ce ´re `de et al. [9]c o n -
structed a mutant strain of T. gondii RH lacking
the mic1a n dmic3 genes (Mic1-3KO). Disrup-
tion of these two genes impairs virulence in
mice [9]. We showed that the Mic1-3KO strain
confers protection against chronic and congeni-
tal toxoplasmosis in mice [27]. We aimed at
demonstrating the efﬁcacy of the Mic 1-3
Knockout Toxoplasma gondii in preventing
abortion in sheep.
Most infections in sheep occur after birth
and are associated with contamination of the
environment with Toxoplasma oocysts derived
from cat faeces [8, 14]. The predominant
lineage of T. gondii strains isolated from
sheep is currently type II [13, 15, 34]. These
ﬁndings justify both the choice of oocysts and
the type II strain to evaluate the efﬁcacy of
Mic1-3KO against abortion in sheep after
challenge based on the natural route of
infection.
2. MATERIALS AND METHODS
2.1. Animals
Thirty-six Bizet ewes aged 12 to 14 months, 54
Romanov ewes aged 12 to 14 months and 33 Solog-
n o te w e sa g e d1 2t o1 4m o n t h s ,s h o w nt ob es e r o n e g -
ative for IgG antibodies to T. gondii by ELISA were
housed in the animal facilities at INRA (Experimental
Infectiology Unit, Nouzilly, France). All animal
experiments undertaken were authorised by the
Direction De ´partementale des Services Ve ´te ´rinaires
(accreditation number: A37805 N 37056).
2.2. Parasites
Mic1-3KO tachyzoites (patent: WO2005/072754)
were obtained by targeted gene disruption of the mic1
and mic3 genes in the DHX RH strain of T. gondii
[9]. Tachyzoites of the live incomplete S48 strain
are sold as a live vaccine for sheep and goats (Ovilis
Toxovax
 ). Mic1-3KO tachyzoites and S48 tachyzo-
ites (donated by J.F. Dubremetz, UMR5235, CNRS,
Universite ´ de Montpellier 2, France) were grown in
human foreskin ﬁbroblast cells (HFF) at 37  Ci n
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) with
4 mM L-glutamine supplemented with 10% fetal
bovine serum (FBS) and 50 U/mL penicillin/50 lg/
mL streptomycin (all Invitrogen, Cergy Pontoise,
France), in a 5% CO2 atmosphere. The culture
medium was replaced by serum-free DMEM 24 h
before harvesting the extra cellular tachyzoites. The
appropriate parasite concentration was obtained
before inoculation by addition of DMEM to a volume
of 1 mL.
RH strain tachyzoites were harvested from the
peritoneal ﬂuids of Swiss OF1 mice that had been
intraperitoneally infected 3 to 4 days earlier. These
were used to prepare the T. gondii antigen (TAg) as
previously described [36].
Sporulated T. gondii oocysts of the PRU strain
(type II strain, donated by M.L. Darde ´, Laboratoire
de Parasitologie-Mycologie; CHRU Dupuytren;
Limoges, France) were obtained from the faeces of
experimentally infected cats.
2.3. Experimental design
2.3.1. Protection against abortion
Three experiments were performed. Ewes were
vaccinated subcutaneously by single injection in the
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peritonealy, two months prior to mating. Pregnancy
wasconﬁrmedbyultrasoundscanat40daysgestation.
Three groups of Romanov ewes were involved in
Experiment 1: (1) non-vaccinated controls (11 ewes),
(2) vaccinated s.c. with 10
5 Mic1-3KO tachyzoites
(12 ewes), (3) vaccinated s.c. with 10
5 S48 tachyzo-
ites (13 ewes). Three groups of Bizet ewes were
involved in Experiment 2: (1) non-vaccinated
controls (12 ewes), (2) vaccinated s.c. with 10
5
Mic1-3KO tachyzoites (12 ewes), (3) vaccinated
s.c. with 2 · 10
6 Mic1-3KO tachyzoites (12 ewes).
Three groups of Solognot ewes were involved in
Experiment 3: non vaccinated controls (11 ewes),
vaccinated with 10
5 Mic1-3KO tachyzoites either
s.c. or i.p (two groups of 11 ewes).
All animals in Experiments 1 and 2 were infected
per-os with 400 sporulated oocysts of PRU strain at
mid-gestation. In Experiment 3, ewes were infected
per-os with 100 sporulated oocysts of PRU strain at
mid-gestation.
2.3.2. Persistence of Mic1-3KO in the brain
of vaccinated ewes
Romanov ewes were inoculated s.c. (n =6 )o ri . p .
(n = 5) with 10
5 Mic1-3KO tachyzoites and 6 ewes
were infected per-os with 400 sporulated oocysts of
PRU strain. Two months after infection, the ewes
were killed and the presence of the parasite in the
brain was determined by Percoll density-gradient
c e n t r i f u g a t i o nf o l l o w e db yd i r e c tm i c r o s c o p y .
2.4. Clinical observations
Rectal temperatures were recorded at intervals for
all sheep after vaccination and challenge. All animals
were monitored daily until lambing was completed.
2.5. Humoral response
Blood was taken from the jugular vein before vac-
cination and at intervals. Sera were tested for the
presence of IgG antibodies against T. gondii by
ELISA using T. gondii antigen as previously
described [26]. The wells were coated with TAg at
10 lg/mL. Serum samples diluted to 1:100 were
added to the wells. Bound antibodies were detected
with a donkey anti-sheep IgG alkaline phosphatase
conjugate (Sigma, St. Quentin Fallavier, France)
diluted to 1:5 000. Experimental ewes before immu-
nisation were used as a negative control. The mean
absorbance of these serum samples + 2 standard
deviations (S.D.) represented the cut off point for a
positive reading.
2.6. Brain cyst load
B r a i nt i s s u ew a sh o m o g e n i s e di n1 0 0m L( l a m b )
or 200 mL (adult) of PBS, containing 100 U/mL
penicillin and 100 lg/mL streptomycin, left over-
n i g h ta t4  C, and then centrifuged in tubes of
50 mL capacity, for 15 min at 300 g. The sediments
were washed with PBS and resuspended in 35 mL
PBS and layered onto 5 mL of 0.9% NaCl/90% Per-
coll (Sigma). After centrifugation for 15 min at
500 g, the interfaces containing cysts were recovered.
The upper phases were collected, washed with PBS
and centrifuged for 5 min at 1 200 g. The resulting
pellets were mixed with the interfaces containing
cysts, washed again with PBS and centrifuged for
5 min at 1 200 g. The ﬁnal pellet was resuspended
in 5–7 mL PBS. The cysts were counted microscop-
ically and the detection limit was 25 cysts per brain.
2.7. Statistical analysis
The Mann–Whitney U-test using GraphPad Instat
2.1 software was used to determine the signiﬁcance
of variations between groups.
3. RESULTS
3.1. Protective efﬁcacy of Mic1-3KO (Exp. 1)
To assess the protective efﬁcacy of the
Mic1-3KO, Romanov ewes were immunised
s.c. with 10
5 Mic1-3KO parasites or with 10
5
S48 tachyzoites [3].
3.1.1. Clinical signs after vaccination
of Romanov ewes
The groups of ewes vaccinated either with
10
5 Mic1-3KO tachyzoites or 10
5 S48 tachyzo-
ites showed a fever that began on day 2 after
vaccination (Fig. 1A). On days 3 and 5, the
mean temperature of the group of ewes
vaccinated with 10
5 S48 (40.5  C±0 . 8 1o n
day 3, 41  C ± 0.59 on day 5) was higher
(p = 0.038 on day 3, p = 0.007 on day 5)
than that of the group of ewes vaccinated
with 10
5 Mic1-3KO (39.9  C ± 0.57 on
day 3, 40.2  C ± 0.69 on day 5). No febrile
Mic1-3KO, vaccine for abortive toxoplasmosis Vet. Res. (2010) 41:49
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Figure 1. Experiment 1 and Experiment 2: Exp. 1, two groups of Romanov ewes received single
vaccinations s.c. by single injection with either 10
5 Mic1-3KO tachyzoites or 10
5 S48 tachyzoites. Exp. 2,
two groups of Bizet ewes were vaccinated s.c. by single injection with either 10
5 or 2 · 10
6 Mic1-3KO
tachyzoites. One group in each experiment was not vaccinated (control). All ewes were challenged per-os
with 400 sporulated oocysts of the PRU strain at mid gestation. (A) Mean rectal ± S.D. temperature of
groups and (B) systemic IgG against T. gondii measured by ELISA after vaccination (mean and S.D.), line
indicates positive cut off point. (C) Mean ± S.D. rectal temperature following challenge.
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vaccinated animals appeared normal and had
no loss of appetite.
3.1.2. Humoral response after vaccination
Animals in the control group did not sero-
convert to T. gondii d u r i n gt h ec o u r s eo ft h e
experiment (Fig. 1B). Serum IgG antibodies
to T. gondii were detected on day 27 following
inoculation with either Mic1-3KO tachyzoites
or S48 tachyzoites (p = 0.0004, p <0 . 0 0 0 1
respectively) and persisted throughout the
experiment (day 150) with no signiﬁcant differ-
ences between the two immunised groups.
3.1.3. Clinical signs after challenge
with 400 oocysts of the PRU strain
The most severe temperature responses were
observed in the control group (Fig. 1C), reach-
ing a peak on day 7 (41.4  C). Ewes vaccinated
with 10
5 Mic1-3KO or S48 tachyzoites showed
a fever that began on day 5 after challenge and
lasted for 2 days before returning to normal by
day 7. The maximum temperatures, 40.3  C
and 39.9  C respectively, were not signiﬁcantly
different (p = 0.18).
3.1.4. Outcome of pregnancy after challenge
at mid gestation
After challenge, all the ewes in the control
group aborted their lambs with a mean gestation
time of 98 days (Tab. I). Nine lambs were
aborted before 105 days gestation (early abor-
tion, less than 15 days after infection) and 2
lambs were aborted after 105 days gestation
(late abortion). Ewes vaccinated with 10
5
Mic1-3KO tachyzoites produced 13 of 21 via-
ble lambs with 8 aborting after 105 days gesta-
tion (late abortion). Ewes vaccinated with 10
5
S48 tachyzoites produced 17 of 25 viable lambs
with 8 aborted lambs after 105 days gestation
(late abortion). No signiﬁcant difference
was observed in expected lambs per ewe in
the two vaccinated groups (KO group:
1.91 ± 0.70; S48 group: 1.92 ± 0.49) or in
the viable lambs born per ewe (KO group:
1.18 ± 1.08; S48 group 1.31 ± 0.94). The mean
gestation times for the ewes that received 10
5
Mic1-3KO or S48 tachyzoites prior to preg-
nancy were 143.4 and 146 days respectively.
The mean gestation time was not signiﬁcantly
different between the two vaccinated groups
but was longer than the mean gestation time
of the control group (p < 0.0001). There was
Table I. The number of viable and non-viable lambs born, and the mean gestation period for each group. In
Experiments 1 and 2, ewes were infected per-os with 400 sporulated oocysts of PRU strain at mid-gestation.
In Experiment 3, ewes were infected per-os with 100 sporulated oocysts of PRU strain at mid-gestation.
Groups Number of
ewes
Number
of lambs
expected
Number of
viable
lambs (%)
Number of non-viable lambs Mean gestation
period ± S.D. Early abortion* Late abortion
Exp. 1 (Romanov ewes)
Control 11 11 0 (0) 9 2 98 ± 16
s.c. 10
5 Mic1-3KO 11 21 13 (62) 0 8 143 ± 4
s.c. 10
5 S48 13 25 17 (68) 0 8 146 ± 3
Exp. 2 (Bizet ewes)
Control 10 10 0 (0) 6 4 122 ± 20
s.c. 10
5 Mic1-3KO 10 11 10 (91) 0 1 158 ± 10
s.c. 2x10
6 Mic1-3KO 11 14 10 (71) 0 4 154 ± 8
Exp. 3 (Solognot ewes)
Control 6 10 0 (0) 1 9 123 ± 21
s.c. 10
5 Mic1-3KO 8 11 7 (64) 0 4 137 ± 10
i.p. 10
5 Mic1-3KO 8 12 11 (92) 0 1 143 ± 6
* Abortion before 105 days gestation.
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viable lambs from the ewes vaccinated with 10
5
Mic1-3KO tachyzoites (2692 ± 788 g) and of
viable lambs from the ewes vaccinated with
S48 tachyzoites (3042 ± 420 g) (p =0 . 0 8 5 ) .
In conclusion, the two vaccines were equally
effective.
3.2. Protective efﬁcacy of two vaccination doses
of Mic1-3KO (Exp. 2)
3.2.1. Clinical signs after vaccination of Bizet
ewes
Following vaccination with 10
5 Mic1-3KO
tachyzoites, a mild febrile response was
observed on day 3 (Fig. 1A). Ewes vaccinated
with 2 · 10
6 Mic1-3KO tachyzoites showed a
febrile response that began on day 2 and lasted
for 1 day before returning to normal by day 4.
The mean temperature reached a peak of
40.5  C for both groups. All animals appeared
normal and had no loss of appetite.
3.2.2. Humoral response after vaccination
Animals in the control group did not
seroconvert to T. gondii during the course of
the experiment (Fig. 1B). Serum IgG antibodies
to T. gondii were detected on day 24 follow-
ing inoculation with either 10
5 or 2 · 10
6
Mic1-3KO tachyzoites (p < 0.0001) and
persisted throughout the experiment (day 134)
with no signiﬁcant difference between the two
vaccinated groups.
3.2.3. Clinical signs after challenge
with 400 oocysts of the PRU strain
The highest temperature responses were
observed in the control group (Fig. 1C) on days
6 and 7 (41.5  Ca n d4 1 . 4 C, respectively).
Ewes vaccinated with 10
5 or 2 · 10
6
Mic1-3KO tachyzoites developed a fever that
began on day 4 after challenge and lasted for
1 day before returning to normal by day 7.
For both groups, the mean temperature reached
ap e a ko f4 1 . 2 C.
3.2.4. Outcome of pregnancy after challenge
at mid gestation
All the ewes in the control group aborted
their lambs after challenge, with a mean gesta-
tion time of 122 days (Tab. I). Six lambs were
aborted before 105 days gestation (early abor-
tion) and four lambs were aborted after 105
days gestation (late abortion). Ewes that
received 10
5 Mic1-3KO tachyzoites produced
10 of 11 live lambs, one lamb was aborted after
105 days gestation (late abortion). Ewes that
received 2 · 10
6 Mic1-3KO tachyzoites pro-
duced 10 of 14 live lambs with four aborted
lambs after 105 days gestation (late abortion).
There was no signiﬁcant difference in the num-
ber of viable lambs per ewe between the two
vaccinated groups (10
5 Mic1-3KO tachyzoites:
1.00 ± 0.471; 2 · 10
6 Mic1-3KO tachyzoites:
0.91 ± 0.83). The mean gestation times for
ewes receiving 10
5 or 2 · 10
6 Mic1-3KO tach-
yzoites prior to pregnancy were 158 and 154
days respectively. These were not signiﬁcantly
different but they were greater than the
mean gestation time of the control group
(p < 0.0001). There was no difference in mean
weight (p = 0.19) of viable lambs from ewes
vaccinated with 10
5 Mic1-3KO tachyzoites
(3410 ± 776 g) and viable lambs from the ewes
vaccinated with 2 · 10
6 Mic1-3KO tachyzoites
(2950 ± 535 g). The two vaccine doses were
equally effective.
3.3. Evaluation of the infection rate of viable
lambs (Exp. 3)
A lower challenge dose was used (100
oocysts instead of 400) to have viable lambs
in the control group. Furthermore, two vaccina-
tion routes were used; Solognot ewes were vac-
cinated either s.c. or i.p. with 10
5 Mic1-3KO
tachyzoites.
3.3.1. Clinical signs after vaccination of Solognot
ewes
A mild febrile response was observed on day
3( Fig. 2A) in the group of ewes vaccinated
s.c. (39.7  C ± 0.692, p = 0.0024, versus the
control group). The group of ewes vaccinated
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vaccination and reached a peak of 40.1  Co n
day 5 (40.1  C±0 . 8 1 3 ,p = 0.006, versus the
control group) before returning to baseline lev-
els by day 7. No febrile responses were detected
in control ewes. All vaccinated animals
appeared normal and had no loss of appetite.
3.3.2. Humoral response after vaccination
Animals in the control group did not sero-
convert to T. gondii during the course of the
experiment (Fig. 2B). Serum IgG antibodies to
T. gondii were detected on day 28 following
either s.c. or i.p. inoculation with 10
5
Mic1-3KO tachyzoites (p <0 . 0 0 0 1v e r s u st h e
control group) and persisted throughout the
experiment (day 74). The mean serological
response was lower following s.c. inoculation
on days 28 and 55 than that following
i.p. inoculation (p =0 . 0 4 a n d p =0 . 0 1 9 ,
respectively).
3.3.3. Clinical signs after challenge
with 100 oocysts of the PRU strain
Vaccinated groups developed a fever that
began on day 5 after challenge, with maximum
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Figure 2. Experiment 3 (Solognot ewes): two groups of ewes were vaccinated by single injection with
10
5Mic1-3KOtachyzoiteseithers.c.ori.p.andwere challengedper-oswith100sporulatedoocystsofthePRU
strainatmidgestation.Onegroupwasinfectedbutnotvaccinated(control).(A)Mean ± S.D.rectaltemperature
of groups and (B) systemic IgG against T. gondii measured by ELISA after vaccination (means and S.D.). The
solid line indicates a positive cut off point. (C) Mean ± S.D. rectal temperature following challenge.
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signiﬁcant difference between the groups. For
both vaccinated groups, temperatures returned
to baseline levels on day 8 whereas the febrile
response persisted until day 9 for the control
group.
3.3.4. Outcome of pregnancy after challenge at
mid gestation
The challenge dose was severe since it
caused 100% fetal mortality in the control
group (Tab. I). However, only one lamb was
aborted before 105 days of gestation (early
abortion) and the other nine lambs were aborted
later (mean gestation period: 120 ± 19). Ewes
thatreceiveds.c.10
5Mic1-3KOtachyzoitespro-
duced 7 of 11 viable lambs with four aborted
lambs after 105 days gestation (late abortion).
Ewes that were inoculated i.p. produced 11
of 12 viable lambs with one aborted lamb after
105 days gestation. There was no signiﬁcant
difference in the number of viable lambs per
ewe (s.c. inoculation: 0.75 ± 0.834; i.p. inocu-
lation: 1.38 ± 0.916) between the two vacci-
nated groups. Furthermore, no signiﬁcant
difference was observed in mean gestation
period (s.c. inoculation: 137 ± 10; i.p. inocula-
tion: 143 ± 6) or in lamb body weight (s.c.
inoculation: 2884 ± 986 g; i.p. inoculation:
2845 ± 999 g).
3.3.5. Cyst load in brain tissue of lambs
No cysts were detected in the brain of 6 of 7
viable lambs born to ewes inoculated s.c. or in
the brain of 11 of 11 viable lambs born to ewes
inoculated i.p. This indicates that these lambs
had < 25 cysts per brain. However, one viable
lamb from ewes inoculated s.c. had 562 cysts.
The number of cysts was analysed in 4 of 10
dead lambs produced in the control group and
in 3 of 4 produced in the group inoculated
s.c. Cysts were detected in the brains of 4 of
4 dead lambs from the control ewes (25, 150,
225 and 300 cysts per brain), in 3 out of 3 dead
lambs from the ewes inoculated s.c. (980, 780
and 275 cysts per brain) and in the dead lamb
from the ewes inoculated i.p. (1025 cysts per
brain).
3.4. Persistence of Mic1-3KO in the brain
of vaccinated ewes
Like the wild type parasite (RH strain),
Mic1-3KO is able to form tissue cysts in mice
that are not, in our experimental conditions,
infectious when given orally [30]. Following
T. gondii infection, tissue cysts are readily
found in sheep tissues, in particular in the brain
and heart [16]. Ewes were inoculated s.c.
(n =6 )o ri . p .( n =5 )w i t h1 0
5 Mic1-3KO tach-
yzoites and six ewes were infected per-os with
400 sporulated oocysts of the PRU strain. The
ewes were monitored for febrile and serological
responses (data not shown). Two months after
infection, the ewes were killed and microscopy
was used to detect the parasite in the brain
(Tab. II).
Tissue cysts were detected in all ewes
infected with oocysts of the PRU strain
(163 ± 127 cysts per brain), in 3 of 6 ewes
vaccinated s.c. with Mic1-3KO (70 ± 31 per
brain) and in 4 of 5 ewes vaccinated i.p.
(52 ± 25). No cysts were detected in the brain
of the other ewes, which indicates that these
ewes had less than 25 cysts per brain.
4. DISCUSSION
We demonstrated that ewes vaccinated with
the Mic 1-3 Knockout Toxoplasma gondii,
developed protection against T. gondii abortion.
To date, successful vaccination strategies have
relied on using a live vaccination approach.
Table II. Brain cysts load in vaccinated sheep.
Oocyst
infection
(PRU)
400 per-os
Mic1-3KO
10
5 s.c.
Mic1-3KO
10
5 i.p.
70* 60 40
50 < 25* 25
67 < 25 60*
150 45 83*
300 < 25 < 25
340 105*
* Bioassayed in mice (see Discussion).
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of the antigen to the sheep immune system. In
three separate experiments, the Mic1-3KO tach-
yzoites readily infected seronegative sheep.
A mild febrile reaction was observed following
inoculation, a clinical sign consistent with
infection of susceptible sheep with T. gondii
[2, 4, 29]. Following s.c. injection of 10
5 S48
tachyzoites the febrile response was more
severe and lasted longer. S48 is lethal for mice;
very low doses [24] are fatal, whereas a high
mortality rate is only observed with  10
6
Mic1-3KO parasites [30]. The Mic1-3KO para-
sites did not multiply at the site of injection
after i.p. injection of mice, and the parasite bur-
den in mouse tissues was less than that caused
by the parental RH strain [30]. In sheep, after
s.c. injection, S48 tachyzoites were shown to
multiply locally, producing parasitemia and
were not detected by bioassay 6 weeks after
infection [1, 39]. As tissue cysts were detected
in mice vaccinated with Mic1-3KO parasites
[30], we analysed the persistence of
Mic1-3KO parasites two months after vaccina-
tion in the brain of vaccinated ewes. Tissue
cysts were detected in 7 of 11 vaccinated ewes.
Three positive (105, 60 and 83 cysts per brain)
and one negative (less than 25 cysts per brain)
concentrated brain homogenates from vacci-
nated ewes were bioassayed in mice together
with one concentrated brain homogenate from
a ewe infected with oocysts (70 cysts per brain).
Half of each concentrated brain homogenate
was injected into naive recipient mice by the
i.p. route and the other half was given orally
to other naı ¨ve mice (data not shown). All the
mice inoculated i.p. or per-os with cysts from
the ewe infected with oocysts became seropos-
itive and cysts were detected in the brain. Cysts
from 1 of 3 positive vaccinated ewes were
infectious by the i.p. route (mice became sero-
positive and cysts were detected in their brain)
but not by the oral route. All other mice were
seronegative and brain cysts were not detected.
The observation that mice inoculated i.p. with
positive concentrated brain homogenates from
vaccinated ewes did not all display positive
serology was probably attributable to the lower
pathogenicity rather than the low cyst fre-
quency. We found that Mic1-3KO cysts from
vaccinated ewes as well as those from vacci-
nated mice [30] were not infectious by the oral
route. The lower pathogenicity but also the low
number of cysts may explain the lack of infec-
tivity by the oral route [30]. Further studies are
needed to clarify these points.
The parental RH strain has lost the ability to
form oocysts in cats [12], however in order to
make Mic1-3KO acceptable for vaccination, it
is necessary to analyse oocyst production
in feces of cats by feeding tissue cysts of
Mic1-3KO to cats.
Antibodies to T. gondii in sera were detected
in all Mic1-3KO vaccinated groups on days
24–28 following inoculation, persisting
throughout the experiments. Since T. gondii
protective immunity in sheep involves cellular
responses [23, 25], diluted whole blood samples
collected three weeks after s.c. inoculation with
10
5 or 2 · 10
6 Mic1-3KO tachyzoites (Exp. 2),
were exposed to T. gondii antigen in vitro (data
not shown). Increased proliferation of PMBC
was seen in a proportion of animals from each
vaccinated group (7 of 12 in the group vacci-
nated with 10
5 tachyzoites; 3 of 11 in the group
vaccinated with 2 · 10
6 tachyzoites) with wide
variation within each group. These results indi-
cate that a cellular response was stimulated.
Ewes with a proliferative response gave birth
to viable lambs, except one ewe with a low pro-
liferative response. It would be interesting to do
further work to determine if this in vitro test
could be a predictive marker of effectiveness.
The immune response as well as the febrile
responses observed were sufﬁcient to deter-
mine whether immunisation of sheep with
Mic1-3KO parasites prior to pregnancy protects
against a challenge in mid-gestation with
T. gondii oocysts. In three independent experi-
ments and in three different strains of ewes
(Romanov, Bizet and Solognot), Mic1-3KO
tachyzoites conferred protection against abor-
tion. A higher rate (91%) of viable lambs from
vaccinated Bizet ewes compared to the two
other strains (62% and 64%) was observed.
Further studies are required to establish whether
the effectiveness of the vaccine is dependent on
the strain of sheep. Congenital transmission of
T. gondii has been found to be infrequent in
Scottish black ewes persistently infected [35]
Mic1-3KO, vaccine for abortive toxoplasmosis Vet. Res. (2010) 41:49
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suggest that persistent infection of sheep by
T. gondii may not prevent foetal infection
[31, 32, 40]. However, further investigation is
needed to assess whether some sheep have
a particular genetic susceptibility to T. gondii.
All ewes from the control groups aborted
whatever the challenge dose. Vaccinated ewes
developed consistently lower febrile responses
to challenge than unvaccinated ewes. Lower
febrile responses may be used as an indicator
of vaccine efﬁcacy [3, 29]. Some ewes in the
control groups aborted in the acute phase of
infection. These early abortions were shown
to occur before the placenta or the fetus had
been invaded by T. gondii [33] and were prob-
ably due to pyrexia and hormonal regulation
[19]. Moreover, after challenge with 400
oocysts, the number of expected lambs was
consistently lower in the control groups than
in the vaccinated groups suggesting resorption
of the fetus. After the lower dose of 100
oocysts, the number of expected lambs was
similar in the control and vaccinated groups
and only one early abortion was recorded in
the control group. The ﬁrst objective was to
assess the efﬁcacy of Mic1-3KO. Hence, a posi-
tive control was included consisting of a group
of ewes vaccinated s.c. with 10
5 S48 tachyzo-
ites which were shown to provide protection
[3]. Under the same experimental conditions,
both strains were equally effective regarding
the number of viable lambs per ewe and the
mean gestation period. These results are similar
to those previously obtained by Buxton et al.
[3]. A vaccination dose of 10
5 Mic1-3KO tach-
yzoites is sufﬁcient to induce a protective
immune response versus a vaccination dose of
2 · 10
6 Mic1-3KO parasites. In view of the
natural penetration of the intestinal tract by T.
gondii, induction of both systemic and mucosal
immune responses would be of interest. The
feasibility of accessing the mucosal immune
system via the serosa by administration of an
intraperitoneal antigen has been explored with
a Salmonella typhimurium vaccine [21, 22].
Solognot ewes vaccinated with 10
5 Mic1-3KO
parasites by the i.p. route developed a febrile
response of longer duration than ewes vacci-
nated by the s.c. route and had a higher level
of anti-T. gondii antibodies on days 28 and 55
than the s.c. group. These results suggest a
higher immunogenicity by the i.p. route than
the s.c. route. However, the increased protection
against abortion provided by the i.p. route ver-
sus the s.c. route was not found to be signiﬁ-
cant. We did not analyze the mucosal immune
response. Meat is the major source of T. gondii
i n f e c t i o ni nh u m a n s[ 28], thus, a vaccine
against T. gondii should prevent the formation
of tissue cysts in mutton or lamb. After chal-
lenge at mid gestation with 100 oocysts, no
cysts (less than 25 cysts) were detected in the
brain of viable lambs born to i.p. vaccinated
ewes and cysts were only detected in one viable
lamb born to s.c. vaccinated ewes. These preli-
minary results are encouraging, and the i.p.
route may be more effective than the s.c. route.
Furthermore, a repeated vaccination, whatever
the route could be more effective.
Mic1-3KO tachyzoites may induce lifelong
immunity as described for natural infection.
T h ed u r a t i o no fi m m u n i t yi ns h e e pa sw e l la s
the efﬁcacy against challenge are still to be
studied.
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